Indivior Pharmaceuticals (INDV) Leases (2022 - 2025)
Historic Leases for Indivior Pharmaceuticals (INDV) over the last 4 years, with Q3 2025 value amounting to $30.0 million.
- Indivior Pharmaceuticals' Leases fell 1891.89% to $30.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.0 million, marking a year-over-year decrease of 1891.89%. This contributed to the annual value of $39.0 million for FY2024, which is 250.0% down from last year.
- Latest data reveals that Indivior Pharmaceuticals reported Leases of $30.0 million as of Q3 2025, which was down 1891.89% from $35.0 million recorded in Q2 2025.
- In the past 5 years, Indivior Pharmaceuticals' Leases ranged from a high of $40.0 million in Q4 2023 and a low of $30.0 million during Q3 2025
- Moreover, its 4-year median value for Leases was $35.0 million (2023), whereas its average is $34.5 million.
- In the last 5 years, Indivior Pharmaceuticals' Leases soared by 2903.23% in 2023 and then plummeted by 1891.89% in 2025.
- Indivior Pharmaceuticals' Leases (Quarter) stood at $31.0 million in 2022, then rose by 29.03% to $40.0 million in 2023, then fell by 2.5% to $39.0 million in 2024, then dropped by 23.08% to $30.0 million in 2025.
- Its last three reported values are $30.0 million in Q3 2025, $35.0 million for Q2 2025, and $37.0 million during Q1 2025.